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Introduction 
I am grateful to you all, the Chairman 
and members of awards committee of In-
dian Psychiatric Society for confering upon 
me the prestigious "Tilak Venkoba Rao 
Oration" Award for 1987. As you all know, 
this oration is instituted in memory of late 
Tilak Venkoba Rao, to encourage young 
psychiatrist to undertake research work in 
field of biological psychiatry. My inspira-
tion for research in psychiatry came from 
Prof. V. N. Bagadia during my postgraduate 
training in psychiatry, at the department of 
psychiatry, Seth G. S. Medical College and 
K.E.M. Hospital. Much work on depression 
had already been done at this department. 
(Bagadia et al 1973a, 1973b, 1973c). My 
work on depression was carried out at this 
department, W.H.O. Collaborating Centre 
for Psychopharmocology in India and at 
other centres where I am still working i.e. 
1) Municipal General Hospital, Rajawadi, 
Ghatkopar, Bombay, 2) Pragati Hospital, 
Mulund and 3) Private Clinic. 
Depression is universal; its clinical fea-
tures were described in ancient Indian lite-
rature by Sudraka, a renowned playwright 
of the 2nd century B.C. (Kale 1972). A dis-
ease of antiguity, depression is an illness 
with a long ancestry. Depressive illness fi-
gures fairly prominently in the sacred wri-
tings of India, its mythologies; literature, 
the twin epics Ramayana and Mahabha-
rata; its folkfore and its ancient medical 
monographs and compendia. The hero of 
Ramayana, Rama suffers from the first epi-
sode in his fifteenth year. Rama's father 
suffers thrice from depression and the third 
attack pfrSves fatal. He dies of grief. Rama's 
grand-father King Aja was a victim of the 
same illness for several years following the 
death of his wife and he starved himself to 
death. This again highlights the heritability 
of depression and the possibility of suicide 
and death from acute depression. Depres-
sion striking Arjuna in the Mahabharata ep-
ic was relieved by Lord Krishna's admoni-
tion and counselling in Bhagavad Gita 
(Venkoba Rao 1984). 
Depression is seen in people of all lands 
and every culture, affecting both the sexes, 
sparing neither the high nor the low, tor-
menting all ages, forcing the exit of some 
through self-destruction and steadfastly 
maintaining its core clinical features down 
the centuries. 
The term "Depression" is so commonly 
used in every-day transactions that it fails to 
convince a layman and a busy medical prac-
titioner that "Depression" could be a clini-
cal entity. The depth and intensity of 
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depression is not usually recognised by the 
relatives or by the physicians. It is one of 
the most agonising illnesses and its real in-
tensity is experienced only by the sufferer. 
In recent years considerable research has be 
done in cases of depression. Though the ae-
tiology has not been unearthed as yet, the 
outcome of treatment of depression has 
been most rewarding. 
The period prevalance of all forms of 
depression has been estimated to be around 
3 per cent per annum., denoting that there 
are about 100 million people in the world 
each year, who develop clinically diagnos-
able and treatable depression (Lehman 
1971). Watt (1966) drew the iceberg model 
of the depressive illness with the visible 
portion comprising 15-20 per 1000. The 
largest invisible portion was formed by 
nearly 150 depressives per 1000 population. 
Though depression is an ubiquitous dys-
phoric experience, few seem to consult 
doctors and still fewer the psychiatrist. Da-
vies and Blashki (1974) found that out of 85 
depressives who consulted general practi-
tioners, only 2 were referred to the psychia-
trists. 
Inspite of this, the volume of depres-
sives, consulting psychiatrist is very large 
and today I shall be concentrating on the 
following areas of depressive illness. 1) Epi-
demiology 2) Clinical profile of depression 
3) Life events and depression 4) ABO 
Blood groups in bipolar and unipolar affec-
tive disorders 5) Tricyclic antidepressants 
6) Tetracyclic antidepressant 7) Multi-
centric collaborative study 8) Pattern of an-
tidepressant use in India. These are the 
areas in which I have personally worked 
and therefore merit greater attention. 
1. EPIDEMIOLOGY 
Earlier notion of the uncommonness of 
depression in India were advanced by some 
British Psychiatrist, appointed to the men-
tal asylums in the country. The data con-
cerning occurence of depression at all levels 
of clinical encounters; in mental hospitals; 
in general hospitals; in psychiatric clinics; 
in general medical practice and in the com-
munity, are now available. The prevalence 
of the illness in the general population in 
the different parts of the country varies 
from 1.21 to 49.1 per 1000 population (Ka-
poor and Singh 1983). 
In view of the lack of reliable estimates 
in the general population, it may be useful 
to look at the incidence figures for depres-
sion within the hospital population. Admit-
tedly, there are several factors which deter-
mine whether a person will seek treatment 
or not, but assuming that these factors will 
operate equally for all psychiatric illnesses 
in a given population, we can get an estim-
ate of the relative frequency of depressive 
illness as compared to other psychiatric di-
sorders. The relative occurrence of depres-
sion in Bombay is an follows: General 
teaching hospital, 9 % of total attendance; a 
private non-teaching hospital patroni£ed-
by middle class, 28% of total attendance 
and a private practice, largely consisting of 
upper-middle and upper class patients, 37 % 
of total attendance (Bagadia et al. 1979a). 
From the various reports (Venkoba Rao 
1984), it appears that the occurrence of the 
depressive illness is four to five times more 
in the northern eastern India than the wes-
tern and southern India. 
The incidence of depression from priv-
ate clinics, is reported to be higher than that 
from teaching general hospital (Table 1). 
When figures from private clinics are com-
pared with other studies from north India, 
incidence is nearly the same. In Bombay, 
general teaching hospitals usually cater for MANILAL GADA  17 
Table 
Percentage of cases of Depre 
Pla.e 
Bombay 
Bombay 
Bombay 
Bombay 
Ludcnow 
chandigarh 
Patiala 
AutKor 
Bagadia et al. 
Vahia et al. 
Bagadia et al. 
Gada 
Sethi & Gupta 
Wig et al. 
Smgh G. 
1973 
1974 
1979 
1980 
1972 
1978 
1979 
lower socio-economic group. The patients 
who can afford to pay, will preferably take 
treatment in private clinic for all illnesses, inc-
luding the psychiatric illnesses. Also, taking 
treatment in general teaching hospitals by 
such affording people is socially disapproved. 
Depression is more common in higher socio-
economic group (Neki and Kapoor 1963, 
Slater and Roth 1969). Thus the incidence of 
depression in western India is similar to that 
reported from eastern and northen India. It 
will be interesting to compare the findings of 
the incidence of depression from teaching 
general hospitals and private clinics from 
other parts of India. The diagnostic criteria 
for depression have been changing from time 
to time and may account for some of the dif-
ferences seen among studies. Yet the impres-
sion remains that the endogenous/psychotic 
variety of depression is more in the North 
and less in the South with intermediate fi-
gures in the West. 
2) CLINICAL PROFILE OF DEPRES-
SION 
Hundred consecutive new cases diag-
nosed as suffering from depression of non-
organic cause according to I.CD.-9 (WHO 
1978) were studied in detail in a prospec-
tive way at Pragati Hospital, Mulund, Bom-
bay (Gada 1982). The presence or absence 
1 
ision at different centres 
Teaching/Private 
General Teaching 
General Teaching 
Private clinic 
Private clinic 
Private clinic: 
General Teaching 
General Teaching 
Percentage 
8.7 
7.6 
37.0 
35.2 
34.2 
29.2 
34.9 
of a particular symptom was rated on Ha-
milton Psychiatric Rating Scale for Depres-
sion (Hamilton 1960). 
The symptoms reported in four other 
studies (two Indian and two British) of de-
pressed patients were compared with the 
findings of the present study. Out of two 
Indian studies, one was from North India 
(Teja et al. 1971) and included 100 cases, 
other was from South India (Venkoba Rao 
1966) and included 30 cases. The other two 
British studies, were from Newcastle 
Upon-Tyne. Kiloh and Garside's (1963) 
study included 143 depressive patients and 
Carney et al. (1965) included 116 depressed 
patients. 
The percentage of symptoms in the 
present study were compared statistically 
with those found in other four studies. 
Chief complaints: 
66% of cases presented with physical 
symptoms only, whereas only 5 % of cases 
had psychological symptoms, 29% cases 
had both physical and psychological symp-
toms (Gada 1980a). More often than not, 
psychiatric patients in our culture complain 
mainly of physical symptoms. Several in-
vestigators from different parts of our 
country (Venkoba Rao 1966, Ansari 1969, 18  PSYCHOBIOLOGY OF DEPRESSION 
Bhattacharya and Vyas 1969, Teja et al. 
1971, Bagadia et al. 1973) have substantiat-
ed thts observation. Similar preponderance 
of physical symptoms have been observed 
among depressed patients from Africa 
(Lambo 1956), from middle east countries 
(Bazzoni 1970), from Bangladesh (Rahman 
1970) and from China (Tseng 1975). 
In psychiatric illnesses, important deter-
minants of the choice of symptoms, include 
those symptoms which are assigned the sta-
tus or an illness by the group to which the 
patient belongs, as well as the expectancy 
on the part of patient of what local doctors 
consider as an illness. The chances of purely 
psychological symptoms being dismissed as 
not or much consequence, are high in India. 
The Indian patient, therefore, uses the 
medium of the body more often for expres-
sing inner tensions, and his depressive affect 
gets translated into the language of the 
body. The differences between the high in-
cidence of hysterical symptoms among In-
dian, and of open anxiety among British sol-
diers, under similar situations of stress dur-
ing last world war, support the same view 
(Williams 1950). 
Symptom Profile: 
Table 2 shows the frequency of symp-
toms of depression seen in 100 cases. 
The present study reveals that 15 of the 
21 symptoms of depression on Hamilton 
Psychiatric Rating Scale for Depression 
were present in more than 60 % of the cases. 
Depressed mood and somatic anxiety were 
present in all the 100 cases, insomnia in 
94%, guilt feelings in 27%, depersonalisa-
tion and derealisation in 14 %, obsession and 
compulsive symptoms in 6% and paranoid 
symptoms in 4%. 
Statistical interpretation of the compari-
Table 2 
Frequency of symptoms in 100 Depressives 
Symptom Percentage 
son of the present findings with those of 
the other four studies are given in Table 3. 
A comparison of my study with that of 
Teja et al. from North India, indicates that 
somatic anxiety was significantly greater 
whereas guilt feelings, late insomnia, work 
and activities, retardation and paranoid 
symptoms were significantly less in my stu-
dy. A comparision with Venkoba Rao's stu-
dy from South India indicates that de-
pressed mood, somatic anxiety, and hypo-
chondriasis were significantly more, whe-
reas suicidal tendency and diurnal variation 
were significantly less in my study. 
All except four symptoms were signifi-
cantly more frequent in my study as 
Depressed mood 
Anxiety. Somatic 
Insomnia, early 
Anxiety, Psychic-
Insight 
Somatic symptoms. 
Somatic symptoms: 
Suicidal tendency 
Hypochondriasis 
Work and activities 
Agitation 
Insomnia, late 
Genital symptoms 
Diurnal variation 
Insomnia, middle 
Retardation 
Feelings of guilt 
gastrointestinal 
general 
Depersonalisation & Dereal  isation 
Obsessional & compulsive symptoms 
Paranoid symptoms 
100 
100 
94 
91 
90 
89 
87 
78 
78 
77 
74 
74 
67 
63 
61 
37 
27 
14 
6 
4 MANILAL GADA  19 
Table 3 
Statistical significant differences in various symptoms compared with present study 
Symptoms 
Present study Present study 
v/s v/s 
Teja et al. Venkoba Rao 
Present study Present study 
v/s v/s 
Kiloh & Garside Carney et al. 
Depressed mood 
Feelings of guilt 
Suicidal tendency 
Insomnia-early 
Insomnia- middle 
Insomnia-late 
Work and activities 
Retardation 
Agitation 
Anxiety psychic 
Somatic symptoms 
Genital symptoms 
Hypochondriasis 
Loss of weight 
Diurnal variation 
Depersonalisation & Derealisation 
Paranoid symptoms 
Obsessional & Compulsive Symptoms 
n.s 
0.01 
n.s 
0.05 
0.05 
0.001 
0.001 
0.001 
n.s 
0.05 
0.01 
n.s 
n.s 
n.s 
n.s 
0.05 
n.s 
0.01 
n.s 
0.01 
-
-
n.s 
-
n.s 
n.s 
n.s 
0.01 
n.s 
0.001 
0.05 
n.s 
-
n.s 
0.001 
n.s 
0.01 
0.001 
-
0.001 
-
n.s 
0.001 
0.001 
-
-
0.001 
0.001 
-
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
-
n.s 
-
0.05 
-
0.001 
0.001 
-
0.001 
0.001 
-
0.05 
-
n.s - not significant 
compared to that by Kiloh and Garside, but 
paranoid and obsessional symptoms were 
significantly less in the present study. Guilt 
feelings and retardation showed no differ-
ence between the two studies. In my study, 
all items were significantly more frequent 
as compared to that of Carney et al. except 
for guilt feelings and paranoid symptoms, 
which were significantly less. 
In my study, guilt feelings were found in 
only 27 % of the cases. The relatively less 
frequent occurence of guilt feelings among 
Eastern patients has been commented on by 
a number of workers. The guilt feelings re-
ported by Indian patients are generally of 
an impersonal character - present suffering 
is usually attributed to possible bad deeds of 
previous life, a consequence of one's 'Kar-
ma'. Individualised guilt is experienced less 
often and that too by the more educated pa-
tients. Conformity is highly valued in the 
Indian social system. An average Indian 
views his life role more as part of a social 
system than as belonging to a unique indivi-
dual. The dictates of the superego continue 
to be dependent on the external sources to a 
fairly large extent. In contrast, the assump-
tion of a greater degree of individual re-
sponsibility and independent role playing 
by the average Westerner is likely to foster 
a sense of: guilt, emanating from one's own 
realisation of self-failure. 
Obsessional and paranoid features are 
encountered to a significantly less extent in 20  PSYCHOBIOLOGY OF DEPRESSION 
Indian as compared to Western depressives. 
Since rituals are a well accepted day to day 
practice of the Indian socio-religious sys-
tem, such features are not likely to be consi-
dered as hampering symptoms by the pat-
ient or by his relatives. In fact, in some cul-
tures, rituals are encouraged, even though 
they may be taxing to the individuals. The 
relatively more competitive existence of 
the Western individual probably tend to 
foster the development of suspicious para-
noid attitudes and this may possibly explain 
the greater frequency of this symptom 
among British depressives. Orelli (1952) in 
Switzerland, studying changes in the con-
tent of depressive delusions during period 
1878-1951, found a significant shift away 
from delusions and feeling of guilt towards 
feelings of personal inadequacy, paranoid 
and hypochondriacal symptoms. 
(3) LIFE EVENTS AND DEPRESSION 
Life without stress cannot be imagined. 
Psychological stresses form an inseparable 
part of the life and upto a degree may be es-
sential for adequate personality develop-
ment. However when these stresses be-
come too severe or too numerous, they may 
affect the psychic equilibrium, producing 
maladaptive patterns and possibly mental 
disorders. The notion that major stressful 
events in life can give rise to mental illness 
is prevalent since antiquity. But scientific 
investigations in this area have been carried 
out only in the last few decades. Lite event 
research is one of the ways of systematically 
studying the relationship between stress 
and illness. 
The basic method in the life event re-
search is determination of significant 
events in the specific period of a person's 
lite and their correlation with subsequent 
illness, physical and/or psychological. Life 
event research is based on the underlying 
presumption that significant events require 
some readjustment in life and produce sig-
nificant upsetting. An accumulation of 
these events in succession produce a non-
specific vulnerability for the development 
or precipitation of physical and psychiatric 
disorders. 
Hundred patients, 64 males, 36 females, 
suffering from Major Depressive Disorder 
(M.D.D) at a private clinic comprised the 
sample for the study. The diagnostic work 
up of the cases was based on R.D.C. as pro-
posed by Spitzer et al. in 1972. 100 normals 
matched for age, sex, marital and economic 
status who had never consulted before for 
psychiatric advice served as control. Both 
these groups were administered life events 
schedule by the author, for finding out 
events experienced in the previous 12 
months. To increase the reliability, 12 
months recall period was used, as recall of 
events in recent time periods is better than 
remote events (Jenkins et al. 1979). Semis-
tructured interview was used and subjects 
were asked to indicate only the occurence 
of events and not its frequency. The period 
of 12 months was divided into 0 to < 1 
month, 1 to < 3 months, 3 to < 6 months 
and 6 to 12 months. For patients, 12 months 
period was before the inception of M.D.D. 
and for the controls it was 12 months pe-
riod before the date of the interview. Life 
events schedule was devised by the author 
to suit the Indian population after modify-
ing the international life events of Holmes 
and Rahe(l967), ofPaykeletal. (1971), and 
of Venkoba Rao and Nammalvar (1976). At 
the time this study was conducted Dr. Gur-
meet Singh's standardized PSLE scale 
(Singh et al. 1981) was not available and 
was probably under investigation. My scale 
contained 72 items. Paykel and co-wor-
kers' (1969, 1975) following comparison MANILAL GADA  21 
methods between events experienced by 
the- patients and controls were used: 
1. Total number and mean number of 
events experienced. 
2. Comparison of frequency of occurence 
of each event between patients and 
controls. 
3. Classification of events into categories 
like: 
a) Exit and entrance from social field. 
b) Desirable and undesirable, in terms 
of shared value of society. 
c) Areas of activity like health, 
employment, family, marital and legal. 
Table 4 
Average number of events 
0 to < 1 1 to < 3 3 to < 6 6 to 12 
month months months months 
No. Ave. No. Ave. No. Ave. No. Ave. 
Control 15 15 28 14 41 13.6 73 12.1 
Patients 37 37" 48 24* 69 23* 101 16.8 
* P < 0.01 
** P < 0.001 
In this study it was observed that de-
pressed patients reported significantly 
more number of life events than normals. 
Also there was clustering of average num-
ber of events particularly one month before 
the inception of depression. 
Saxena and Mohan (1982) have dis-
cussed excellently the methodological is-
sues about life events research. In the pres-
ent study, many of the issues were taken 
care of even before Saxena and Mohan's 
guideline for • life-events research were 
available. 
Venkoba Rao and Nammalvar (1976), 
Prakash et al. (1980), Chatterjee et al. 
(1981), Gupta et al. (1981) have reported 
association between life events and depres-
sion. Brown (1972) has advanced the con-
cept of "brought forward time" which is de-
rived from elaborate calculations. Essential-
ly it supposes that the illness was any way 
destined to begin in future and stressful 
events bring this onset nearer. 
Considerable caution must be exercised 
in assigning causal relationship between 
events and illness. It should not be forgot-
ten that life events constitute only one of 
several factors in the causation of illness. 
(4) ABO BLOOD GROUPS IN BIPO-
LAR AND UNIPOLAR AFFECTIVE DI-
SORDERS : 
One of the methods of studying the as-
sociation between a psychiatric disorder 
and established genetic traits has been the 
determination of ABO blood groups. 
A number of studies have been reported 
on the association between affective di-
sorders and ABO blood types. Some work-
ers (Parker et al. 1961; Masters 1967; 
Mendlewicz et al. 1974) have reported sig-
nificantly greater incidence of the type O 
blood group in manic-depressive group. 
Others (Tenna and Winokur 1968; Fle-
menbaum and Larson 1976) have not con-
firmed the same. All these workers have 
considered manic-depressive illness as one 
single entity. The unity of manic-depres-
sive illness as defined by Kraeplin (1921) 
has been questioned by several investigators 
(Leonard 1966; Perris 1966) who have pre-
sented clinical and genetic evidence that 
the disease is heterogenous and consists of 
two distinct types, unipolar and bipolar af-
fective disorders. The overrepresentation 
of any one of the two subcategories may 22  PSYCHOBIOLOGY OF DEPRESSION 
Type 
Bereavement 
Health 
Financial 
Family/relatives 
Occupation 
Education 
Legal 
Migration 
Others 
•p<0.01 
Individual events 
0-<l 
Nor. 
N- 15 
2 
3 
1 
3 
2 
1 
0 
1 
2 
•p< 0.001 
month 
Dep. 
N-37 
9" 
10' 
3 
7 
2 
2 
0 
1 
3 
0-1 month 
Nor. 
N- 15 
Dep. 
N-37 
Type 
0-
Nor 
N-
6 
6 
9 
10 
6 
1 
1 
2 
2 
In 
0-
Nor 
N-
< 
42 
Table 5 
of life events 
3 months 
Dep. 
i N-85 
16* 
20* 
18 
14 
6 
4 
2 
2 
3 
Table 6 
dividual events 
-3 
43 
months 
Dep. 
N-85 
0-<6 
Nor. 
N-84 
9 
17 
21 
21 
6 
4 
1 
2 
3 
months 
Dep. 
N- 154 
25 
39 
32 
31 
11 
6 
2 
3 
5 
0-6 months 
Nor. 
N-84 
Dep. 
N-154 
0-
Nor 
N-
15 
31 
40 
38 
15 
7 
3 
3 
5 
0-
Nor 
N-
<12 
IV 
months 
Dep. 
N-255 
37 
56 
53 
49 
21 
16 
5 
10 
8 
12 months 
157 
Dep. 
N-255 
1 Serious Personal 
Physical Illness 0 
2 Minor Personal 
Physical Illness  1 
4 Academic Failure 0 
12 Law Suit 
13 Death ot Spouse 
15 Serious Illness 
of Spouse 
16 Minor Illness 
of Spouse 
17 Scrums 
Arguments 
with Spouse 
29 Death of Child 
30 Serious Illness 
of Child 
31 Minor Illness 
of Child 
^i Serious 
Arguments with 
Child 
40 Death ot parents 
0 
0 
0 
0 
0 
0 
0 
1 
1 
i 1 
2 
1 
0 
2' 
2' 
1 
1 
2' 
2' 
1 
2 
2 
1 
1 
1 
. 0 
0 
1 
1 
1 
0 
2 
3 
1 
3 
2 
2 
3* 
4" 
2 
3 
4 
3 
2 
4 
4 
2 
2 
1 
0 
1 
3 
2 
2 
1 
4 
6 
2 
8 
4 
2 
5" 
5 
4 
6 
7 
5 
4 
8 
5 
4 
3 
3 
1 
3 
5 
4 
3 
3 
7 
10 
3 
12 
8 
5 
7' 
8 
7 
9 
10 
8 
6 
13 
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49 Unemployment 
(of patient) 0 1 12 2 4 3 6 
59 Business Failure 0 1 12 3 5.48 
61 Major Financial 
Difficulties 0 1 2 6 5 10 9 15 
69 Serious 
Arguments with 
Neighbour 0 0 2 1 3 4 4 6 
Table 7 
Number of markedly threatening events 
0 - < 1 month 1 - < 3 months 3 - < 6 months 6 - < 12 months 
No. Ave. No. Ave. No. Ave. No. Ave. 
Control 2 2 3 1.5 5 1.6 6 1 
Depressed patients 12 12" 10 5* 14 4.6' 13 2.1 
*p<0.01 "p< 0.001 
give rise to erroneous findings and true re-
lationship may disappear. This may account 
for the inconsistent findings of the investi-
gators. 
In four studies (Shapiro et al. 1977, 
Beckman et al. 1978, Riniers et al. 1979, 
Singh et al. 1979) and one conducted by the 
author (Gada 1986) the dichotomy of ma-
nic-depressive illness (i.e. division into uni-
polar and bipolar affective disorders) has 
been realised. 
As part of a clinical study of primary af-
fective disorders, it was decided to investig-
ate the ABO blood groups of all probands 
attending municipal general hospital, Raja-
wadi, Ghatkopar, Bombay. In addition to a 
diagnosis of affective psychosis according 
to the International Classification of Dis-
ease (9th revision), all subjects were re-
quired to fulfill the R.D.C. as proposed by 
Feighner et al. (1972) for inclusion in the 
present study. No one was admitted to the 
study who had evidence of another pre-
existing psychiatric illness. The designation 
of patients as unipolar or bipolar was made 
according to the following criteria, a) Pa-
tients with at least one definitely manic epi-
sode at the time of index admission or in the 
past, with or without a definite depressive 
episode, were diagnosed as bipolar, b) For 
diagnosis of unipolar illness the criterion of 
at least two definite depressive episodes, as 
proposed by Mandlewicz and Rainer (1968) 
and also Johnson et al. (1977) was used, 
c) In addition any subject with a history of 
mania, in any family member, was excluded 
from the unipolar group, d) Patients with 
only one episode of depression or a mixed 
picture, although fulfilling the criteria for 
primary affective disorders, were consi-
dered of uncertain polarity and therefore 
excluded from the study. 
Blood group frequencies for the general 
population were calculated from the re-
cords of the subjects registered and tested at 
the blood bank of Municipal General Ho-
spital, Rajawadi, Ghatkopar. 
Comparison of the bipolar group with 
normal controls' (x
2 = 11.372, d.f. 24  PSYCHOBIOLOGY OF DEPRESSION 
Table 8 
Distribution of ABO Blood Groups in Bipolar and Unipolar patients and Normal Control; 
ABO 
O 
A 
B 
AB 
Norma 
Perceni 
36.0 
25.0 
31.0 
8.0 
1 controls 
tage 
Bipo 
(N-
No. 
29 
9 
15 
3 
lar 
56 
patients 
) 
Percentage 
51.8 
16.1 
26.8 
5.3 
Urn 
(N = 
No. 
16 
9 
15 
4 
polar patients 
= 44) 
Percentage 
36.4 
20.4 
34.1 
9.1 
Total 
(Bipol 
(N = l 
No. 
45 
18 
30 
7 
lar + Unipolar) 
100) 
Percentage 
45.0 
18.0 
30.0 
7.0 
= 3 p < 0.01) and with unipolar group (x
2 = 
11.510, d.f. = 3, p <0.01) on total distribu-
tion of blood groups showed a significant 
ditference suggesting that the bipolar 
group was different from the normals and 
unipolar group. A closer examination of the 
individual blood types revealed that the bi-
polar group had significantly higher per-
centage of cases with blood group O than 
either normal controls (X
2 = 4.100, d.f. = 1, 
p<0.05) or unipolar group (X
2 =4.133, 
d.f. = 1, p < 0.05). No significant difference 
was observed in other blood groups. 
In the case of the unipolar group no sig-
nificant difference were found when com-
pared to controls for total distribution of 
blood groups or any of the blood groups. 
When manic-depressive illness is divid-
ed into unipolar and bipolar affective di-
sorders, the consistent tinding emerges, i.e. 
bipolar atfective group has significantly 
higher frequency of blood group O in com-
parison to normal controls and unipolar af-
fective group. In both the Indian studies 
unipolar atfective patients, were not differ-
ent from normal controls as far as ABO 
blood group was concerned. 
It would be reasonable to postulate that 
blood group factors represent one among 
other relevant genetic variables. The 
contribution of blood group variation in 
disease susceptibility is justifiable to the asser-
tion that blood group association imply the 
hereditary aspect in the aetiology of a disease. 
Pharmacotherapy of Depression 
The first drug shown to be therapeuti-
cally effective in the treatment of depres-
sion was imipramine. Its possible anti-de-
pressive properties were recognised as early 
as 1956 (Kuhn 1957) and soon further subs-
tantiated independently in Europe (Kiel-
holz and Battergay 1958) and North Ame-
rica (Lehman et al. 1958). In spite of its great 
practical implications, however, it was not 
until 1959 that the first controlled trial de-
finitely confirmed the anti-depressant ef-
fects of imipramine (Ball and Kiloh 1959). 
Since then, a rather large number of imi-
pramine like tricyclic and tetracyclic anti-
depressants (TTA) have been synthesized 
and employed clinically (Ban 1974). Origi-
nally TTA were a structurally homogenous 
group of tricyclic anti-depressants with the 
common pharmacological property of 
blocking the reuptake of biogenic amines, 
primarily norepinephrine and serotonin, 
across the presynaptic neuronal cell mem-
brane. Today they are a structurally heteroge-
neous group of drugs, with atleast ten differ-
ent tricyclic and ten different non-tricyclic MANILAL GADA  25 
structures, possibly with a common final 
path in affecting noradrenergic transmis-
sion by down-regulation of beta-receptors 
in postsynaptic neurons (Creese and Sib-
ley 1981). Although there is no evidence 
for different therapeutic actions, these 
drugs differ in their adverse effects, such as 
those associated with their hypotensive, se-
dative and anti-cholinergic properties. 
These effects seem to be linked to affinities 
for alpha! adrenergic receptor, histaminei 
receptors and acetylcholine muscarinic re-
ceptors, respectively (Richelson 1979). Fur-
thermore, by the demonstration of a de-
crease in the number of imipramine bind-
ing sites, the possibility of a biological mar-
ker for therapeutic responsiveness to TTA 
has become distinct possibility (Briley et al. 
1982). 
(5) TRICYCLIC ANTI-DEPRESSANTS: 
A six week double-blind controlled 
comparative trial of amoxapine and imi-
pramine was carried out in 66 depressed pa-
tients of both sexes attending the outpat-
ient department of a general teaching ho-
spital (Bagadia 1979b). Physical examina-
tion and psychiatric evaluations (Hamilton 
Psychiatric Rating Scale for Depression, 
Beck Depression Inventory and Clinical 
Global Impression Scale) were applied pre-
treatment and at weekly intervals for the 
entire duration of the trial (six weeks). 
Forty-eight patients completed the 
study of 6 weeks. Results are as follows, 
by the end of second week there was good 
response in 25 per cent of cases. At the end 
of fourth week response was excellent in 
25 per cent and good in another 52 per 
cent of the cases. By the end of sixth week 
91.6 per cent had improved (excellent re-
sponse in 60.4 per cent and good in 
31.2 per cent). In endogenous depression 
96.1 per cent of the cases had shown good 
to excellent response, where as in neurotic 
depression 13.6 per cent had not improved. 
The side effects consisting mainly of anti-
cholinergic (dry mouth, constipation, de-
layed urine flow) and neurological (giddin-
ess, tremor) symptoms, were mild, were to-
lerated by the patients on reassurance and 
acceptable to the physicians. 
(6) TETRACYCLIC ANTI-DEPRESS-
ANT (MAPROTILINE) 
A four week, double blind comparative 
clinical study with 72 depressed psychiatric 
patients, was carried out, in which patients 
were randomly assigned to low or high dos-
age schedule, in a single daily dose given at 
bed time. Thus, patients of the low group 
were given maprotiline in the dosage of 
37.5 mg. daily for three days and 75 mg. da-
ily subsequently, while patients of the high 
dose group were administered a dosage of 
75 mg. daily for three days and a dose of 150 
mg. daily until the end of the 28 days treat-
ment period. 
Assessments were based on clinical in-
?rviews and the completion of three psy-
chiatric rating scales i.e. Clinical Global Im-
pression Schedule, Hamilton Psychiatric 
Rating Scale for Depression (HAM-D) and 
Rating Scale for Side Effects, (RSSE) be-
fore, the 14th, 28th, 42nd and 84th day of 
drug administration. 
Fiftynine patients completed 4 weeks of 
study and 49 patients completed total pe-
riod of 12 weeks. Of 59 cases, 8 (13.6%) 
were of moderte severity and 51 (86.4%) 
had severe depression. 
Scores of the Global Improvement did 
not differ statistically in the low and high 
dosage groups after two and four weeks of 26  PSYcHOBIOLOGY OF DEPRESSION 
Table 9 
Summary of key indicators giving mean total scores at each evaluation 
Scale 
Hamilt< 
Beck 
c.G.I 
AMO -
IMP -
3n 
- A 
Imi 
AMO 
IMP 
AMO 
IMP 
AMO 
IMP 
moxapine 
ipramine 
Baseline 
38.1 
36.9 
22.4 
21.1 
3.0 
3.0 
Week 
1 
33.9 
33.3 
20.5 
19.9 
2.9 
3.0 
Week 
2 
25.8 
25.3 
15.6 
15.2 
2.7 
2.8 
Week 
3 
20.0 
16.5 
11.7 
10.0 
2.4 
2.3 
Week 
4 
13.0 
10.8 
8.3 
6.5 
2.0 
1.9 
Week 
5 
8.9 
6.6 
5.1 
3.7 
1.8 
1.5 
Week 
6 
6.1 
5.3 
3.5 
2.8 
1.6 
1.4 
Table 10 
Hamilton psychiatric rating s^ale for depression mean total scores 
Evaluation 
Initial 
At 2 Weeks 
At 4 Weeks 
Low Dose  High Dose 
24.75 
14.44 
11.19 
23.59 
14.41 
11.33 
Total 
24.22 
14.22 
11.25 
treatment although the scores did show sig-
nificant improvement in each group. By se-
parating patients into three groups, (A) im-
proved, (B) unchanged and (C) worsened, 
84.4 % of the patients in the low and 85.2 % 
of the patients in the high dosage group 
were judged to be improved at the end of 
four weeks treatment. 
Table 10 shows: there was statistically 
significant improvement in total scores, all 
five factor scores and 15 of the 17 item 
scores on HAM-D in the total population 
after two weeks of treatment; and in one 
more item score by the end of the fourth 
week. Analysis of covariance did not reveal 
any statistically significant difference bet-
ween the two groups for any item, factor or 
total score. 
The side effects observed (on RSSE) 
were drowsiness, constipation, tremor, 
orthostatic symptoms, dryness of mouth, 
perspiration and micturition difficulties. 
Analysis of covariance indicated that high 
dose patients had a significantly greater in-
crease (worsening) in total scores and in the 
item scores of constipation and orthostatic 
symptoms than low dose patients. 
(7) DOSE EFFECTS OF ANTI-DE-
PRESSANT MEDICATION IN DIFFER-
ENT POPULATIONS - A WORLD 
HEALTH ORGANISATION COLLA-
BORATIVE STUDY: 
Patients included in the study were 370 
adults (WHO 1986). There were 31 pa-
tients in Basel, 72 in Bombay, 68 in Cali, 54 
in Lucknow, 35 in Nagasaki, 41 in Nash-
ville and 69 in Sapporo, 324 patients were 
available for the final analysis (in 30 pa-
tients no second assessment was avail-
able and 16 patients were excluded prior to 
completing 4 days of active treatment) with 
adequate representation from each centres. 
The clinical study consisted of three dis-
tinct phases which were conducted on the MANILAL GADA  27 
basis of an identical protocol at all centres. 
The first phase of the study followed a con-
ventional, design in which patients were 
randomly assigned to one of two, a low and 
a high, dosage regimes (day 0) and treated 
on the basis of a fixed changing dosage 
schedule in a double-blind manner over a 
period of 28 days (days 1-28). Patients of 
the low dose group were given 37.5 mg. da-
ily for three days and 75 mg. daily 
subsequently, while patients of the high 
dose group were administered a dosage of 
75 mg. daily for three days and a dose of 
150 mg. daily until the end of the 28 days 
treatment period. Subsequently, during the 
second phase of the study, patients were 
treated on the basis of a flexible dosage re-
gime in an open manner over a period of 14 
days (days 29-42) with the same drug used 
during the first phase. By allowing for free 
adjustments of the dose, it was hoped that 
optimal therapeutic dose levels would be 
attained. Finally, during the third phase of 
the study patients were treated in a comple-
tely free and open manner, with drugs or 
other treatments, at the discretion of the 
attending psychiatrist for an additional pe-
riod of 42 days (days 43-84). 
The parameters of assessment were (1) 
Part 2 (symptom and signs) of WHO Sche-
dule for Standardized Assessment of De-
pressive Disorders (WHO/SADD), 
(2) Hamilton Psychiatric Rating Scale for 
Depression (HAM-D), (3) Rating Scale for 
Side Effects (RSSE) and (4) Clinical Global 
Impression Scale (CGIS). 
The salient findings were as follows: 
1) Most patients selected for the treat-
ment in this investigation showed a good 
response during the first 28 days. 
2) No statistically significant difference 
was found between the response to treat-
ment, as measured on HAM-D total score, 
the Clinical Global Impression of Severity 
and all the items of the HAM-D taken sepa-
rately. 
3) The response to treatment showed 
significant differences between centres. 
Follow-up 
There was an inverse relationship bet-
ween Efficacy Index (El) and rate of conti-
nuation for amitriptyline and imipramine 
patients, i.e. the greater the improvement 
(and the fewer the side effects) the more li-
kely it was that there will be a continuation 
of treatment with these drugs. In this re-
spect, patients who continued for 42 days 
did not differ from those who continued 
over the entire 84 day period. These 
findings also imply that patients who re-
spond favourably to treatment are most li-
kely to continue with the maintenance the-
rapy. 
Treatment Emergent Symptoms 
The Rating Scale for Side Effects, con-
sisting of 13 items, was used to record treat-
ment emergent symptoms, i.e., manifesta-
tions with an onset during the course of 
treatment. Tremor and nausea/vomiting 
occured statistically significantly more 
often in the high than in the low dose 
group. 
8) PATTERN OF ANTIDEPRESSANT 
USE BY INDIAN PSYCHIATRISTS 
A study by questionnaire was carried 
out at the W.H.O. Collaborating Centre 
for Psychopharmacology in India (Bom-
bay) to ascertain prescribing patterns, 
choice of drugs, dosage, duration, side ef-
fects and concurrent use of other modalities 
of treatment by Indian Psychiatrists in de-
pressed patients (Gada et al. 1984). The 28  PSY..HOBIOLOGY OF DEPRESSION 
results analysed, from the replies received, 
were as follows: 
Iniipramine and amitriptyline were the 
two most commonly used antidepressant 
drugs in India. More than 80% of Indian 
Psychiatrists, use imipramine and amitrip-
tyline as either first or second choice of an-
tidepressant drugs. Three fourths ot the 
psychiatrists use upto 150mg. per day as a 
therapeutic dose and upto 75 mg. per day as 
maintenance dose. Two thirds use thera-
peutic dose lor less than 3 months whereas 
half of the psychiatrists use a maintenance 
dose for less than 6 months. Ninety-seven 
percent of the Indian psychiatrists use 
electro-convulsive therapy and psychothe-
rapy, concurrently with antidepressant 
drugs. Commonest side effects observed on 
Indian patients are dryness of mouth, cons-
tipation, and drowsiness. Commonest con-
traindication for use of the anti-depressant 
drugs in India are glaucoma, enlarged pros-
tate, recent myocardial infarction and other 
cardiac diseases. 
In children, apart from its use in depres-
sion, antidepressant drugs are used in enur-
esis, hyperkinetic behaviour and school 
phobias. 
The response of majority of Indian de-
pressed patients to tricyclic and tetracyclic 
antidepressant drugs is good to excellent 
and usually occurs within two to six weeks. 
Tolerance to these drugs is also reportedly 
good. 
All human beings are biological, psy-
chological and sociological creatures. It is 
the interaction of all these factors that leads 
to an illness, more so as psychiatric illness. 
Depression is an illness with multifactorial 
aetiology. Interplay ot psychosocial and 
biological factors i.e. psychobiological 
aspects, leads to depression. Life events by 
themselves or biological predisposition by 
itself will not produce the illness. 
In the psychobiology of depression 
there are many more areas like genetic stu-
dies, twin studies, family studies indicating 
X-linkage, relation to colour-blindness. 
There are biochemical studies, indicators of 
vulnerability in the RBC enzyme systems, 
classification according to suppression or 
otherwise of dexamethasone (DST), treat-
ment by electroconvulsive therapy, trypto-
phan and diet regulation, newer antidepres-
sants like bicyclics etc., etc. These are areas 
in which as of date, I have not ventured but 
given the opportunities, I intend to conti-
nue research in this sphere which presently 
myriad openings for further investigations. 
Radhakrishnan once remarked that 
"Science humbles its votary and it makes 
him realise how little he knows and how 
vast is the unknown". Extending the fronti-
ers of knowledge, rather than solving the 
mystery heightens it. It will be appropriate 
to conclude this oration by these lines of 
Rabindranath Tagore: 
This is my prayer to thee, my Lord — 
Strike, Strike at the root oj penury in my heart, 
Give me the strength lightly to bear joys and 
sorrows, 
Give me the strength to make my love fruitful in 
service, 
Gif e me the strength never to disown the poor or 
bend my knees bejore insolent might. 
Give me the strength to raise my mind high 
above daily trifles. 
And give me the strength to surrender my 
strength to thy will with love. 
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